Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.30 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.30 |
| ▸ | AHR | P35869 | 2/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17740647 | 0.95 | GPR3 (0.37) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL24527196 | 0.93 | MAPT (0.37) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL19151971 | 0.93 | AHR (0.37) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL22505860 | 0.91 | CYP1A2 (0.33) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL23370908 | 0.90 | CYP1A2 (0.35) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL24000248 | 0.90 | CYP1A2 (0.35) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL24000291 | 0.90 | MAPT (0.37) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL24000698 | 0.90 | CYP1A2 (0.35) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL24000317 | 0.89 | ESR2 (0.35) | GPR3ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL22741391 | 0.89 | CYP1A2 (0.34) | GPR3ALDH1A1MAPTHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11834457-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, display device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2023-12-05 | — | — | US | disclosed |
| US-11834457-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, display device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2023-12-05 | — | — | US | disclosed |
| US-20220194954-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Display Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2022-06-23 | — | — | US | disclosed |
| US-11225488-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, display device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2022-01-18 | — | — | US | disclosed |
| US-20210347782-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Display Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2021-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11834457-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, display device, and lighting device | SLCO4C1, SLCO2A1, DDT | GPR3 2615/4885ALDH1A1 367/4885MAPT 748/4885 |
| US-20220194954-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Display Device, and Lighting Device | SLCO4C1, SLCO2A1, SLCO2B1 | GPR3 2297/4885ALDH1A1 431/4885MAPT 1001/4885 |
| US-11225488-B2 | Organic compound, light-emitting element, light-emitting device, electronic device, display device, and lighting device | SLCO4C1, SLCO2A1, DDT | GPR3 2615/4885ALDH1A1 367/4885MAPT 748/4885 |
| US-20210347782-A1 | Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, Display Device, and Lighting Device | SLCO4C1, SLCO2A1, DDT | GPR3 2615/4885ALDH1A1 367/4885MAPT 748/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.